Literature DB >> 21495261

Investigation of distribution and elimination of terbutaline sulfate in the perfused rat liver preparation.

Selma Sahin1, Yasemin Karabey.   

Abstract

Hepatic distribution and elimination of terbutaline sulfate (TBS) was investigated in the in situ isolated perfused rat liver preparation. Perfusion experiments were conducted using Krebs bicarbonate buffer delivered via the portal vein in a single-pass mode at a total flow rate of 15 mL min(-1). TBS was administered as a bolus (2 mg mL(-1)) in the absence and presence of erythrocytes (50% hematocrit) or albumin (1%). Immediately after a bolus administration, the outflow perfusate was collected and then concentration of TBS was determined by a validated HPLC method. Regardless of the condition, the extraction of TBS (0.35-0.51) across the liver during single pass was intermediate. Although protein binding of TBS was very low (2.5%), it was taken up slowly and continuously by erythrocytes. A blood to plasma concentration ratio of 2.8 obtained at the end of incubation period clearly indicates that TBS has an affinity to erythrocytes. However, under the conditions used in this study, hepatic distribution and elimination of TBS were not influenced by the presence of erythrocytes or albumin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21495261     DOI: 10.1007/s13318-010-0002-0

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  24 in total

1.  Human erythrocytes are not suitable for determination of intravascular volume of perfused rat liver.

Authors:  Y Karabey; S Sahin
Journal:  Methods Find Exp Clin Pharmacol       Date:  2006 Jul-Aug

2.  Uptake of lactate by the liver: effect of red blood cell carriage.

Authors:  C A Goresky; G G Bach; A Simard; A J Schwab; A Bracht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-05       Impact factor: 4.052

3.  Pharmacokinetics of intravenous terbutaline in asthmatic children.

Authors:  C Hultquist; C Lindberg; L Nyberg; B Kjellman; G Wettrell
Journal:  Dev Pharmacol Ther       Date:  1989

4.  The metabolism of terbutaline in dog and rat.

Authors:  H T Nilsson; C G Persson; K Persson; K Tegnér; A Ryrfeldt
Journal:  Xenobiotica       Date:  1973-09       Impact factor: 1.908

5.  Estimation of aqueous distributional spaces in the dual perfused rat liver.

Authors:  S Sahin; M Rowland
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

6.  Estimation of hepatic distributional volumes using non-labeled reference markers.

Authors:  Yasemin Karabey; Selma Sahin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Oct-Dec       Impact factor: 2.441

7.  Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres.

Authors:  Selma Sahin; Handan Selek; Gilles Ponchel; Meral T Ercan; Mustafa Sargon; A Atilla Hincal; H Süheyla Kas
Journal:  J Control Release       Date:  2002-08-21       Impact factor: 9.776

8.  Pharmacokinetics of terbutaline after oral administration.

Authors:  D S Davies
Journal:  Eur J Respir Dis Suppl       Date:  1984

9.  Transfer of terbutaline across the human placenta in late pregnancy.

Authors:  B Bergman; H Bokström; O Borgå; L Enk; T Hedner; B Wängberg
Journal:  Eur J Respir Dis Suppl       Date:  1984

10.  Quantitative estimation of myocardial fibrosis based on receptor occupancy for beta2-adrenergic receptor agonists in rats.

Authors:  Satoru Tanaka; Yasunori Momose; Masaru Tsutsui; Tomoyuki Kishida; Junji Kuroda; Nobuo Shibata; Takemi Yoshida; Ryoichi Yamagishi
Journal:  J Toxicol Sci       Date:  2004-08       Impact factor: 2.196

View more
  1 in total

1.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.